kabutan

HOGY MEDICAL, First Half Ordinary Profit Decreases by 44%, Jul-Sep Ordinary Profit Decreases by 62%

Mon Oct 27, 2025 3:30 pm JST Earnings

3593 HOGY MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

HOGY MEDICAL CO.,LTD. <3593> [TSE Prime] announced its financial results after the market closed on October 27th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) dropped 44.0% from the same period last year to 1.14 billion yen. Progress toward the full-year plan of 2.59 billion yen was 44.0%, also falling below the five-year average of 51.0%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to decrease 9.9% from the same period last year to 1.45 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit significantly dropped to 0.24 billion yen, a 61.8% decrease compared to the same period last year. The operating profit margin drastically worsened from 7.6% in the same period last year to 3.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 19,536 2,375 2,373 1,732 71.4 55.9 Oct 12, 2023 J-GAAP
Apr - Sep, 2024 19,619 2,083 2,036 1,867 80.6 55.9 Oct 10, 2024 J-GAAP
Apr - Sep, 2025 18,857 1,277 1,140 907 42.1 44.0 Oct 27, 2025 J-GAAP
YoY -3.9% -38.7% -44.0% -51.4% -47.7%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance 18,857 1,277 1,140 907 42.1 47.50 Oct 15, 2025 J-GAAP
Apr - Sep, 2025 Results 18,857 1,277 1,140 907 42.1 47.50 Oct 27, 2025 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% +0.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 19,519 1,727 1,609 -347 -15.5 40 Apr 24, 2025 J-GAAP
Oct - Mar, 2025 Guidance 20,383 1,493 1,450 1,123 52.1 47.50 Oct 15, 2025 J-GAAP
YoY +4.4% -13.5% -9.9% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 39,100 4,169 4,245 2,804 115.6 80 Apr 10, 2024 J-GAAP
Mar, 2025 39,138 3,810 3,645 1,520 68.0 80 Apr 24, 2025 J-GAAP
Mar, 2026 Guidance 39,240 2,770 2,590 2,030 94.2 95 Oct 15, 2025 J-GAAP
YoY +0.3% -27.3% -28.9% +33.6% +38.5%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 9,894 748 631 861 37.2 7.6 Oct 10, 2024 J-GAAP
Oct - Dec, 2024 10,397 1,323 1,233 869 38.4 12.7 Jan 16, 2025 J-GAAP
Jan - Mar, 2025 9,122 404 376 -1,216 -54.4 4.4 Apr 24, 2025 J-GAAP
Apr - Jun, 2025 9,375 950 899 732 34.0 10.1 Jul 25, 2025 J-GAAP
Jul - Sep, 2025 9,482 327 241 175 8.1 3.4 Oct 27, 2025 J-GAAP
YoY -4.2% -56.3% -61.8% -79.7% -78.1%

Related Articles